NEWS & EVENTS
Identifying new compounds to treat heart disease, cancer, or other inflammatory and immune-related disorders may get easier using a precisely tailored application of solid state nuclear magnetic resonance (NMR) spectroscopy–which can reveal a protein’s entire 3-D structure within its natural surroundings.
A team of researchers including NIBIB investigator Kit Lam at the University of California Davis has discovered a new class of nanoparticles capable of packaging a diverse array of drugs. Research findings demonstrate structural and dynamic changes within nanoparticles during interaction with blood proteins which will result in better designed nanomedicines that will be therapeutically more efficacious. Read the full article from ACSNano.
Led by a grant from the National Science Foundation (NSF), Mark Chance, PhD, director of the Center for Proteomics and Bioinformatics at Case Western Reserve University School of Medicine, has been awarded $4 million for work with the National Synchrotron Light Source II (NSLS II) at Brookhaven National Laboratory in New York. Read the full news release from Medicus.
Dr. Joachim Kohn, AFIRM's Director and an NIBIB Principal Investigator, takes people ravaged by war and helps discover new ways to put them (literally) back together through tissue engineering, renerative processes like bone and nerve repair, face transplants, human transplantation, and an engineered skin substitute for burns. Read the full article from Wired.com.
A new study by University of Kentucky researchers, carried out in the laboratory of Pexiuan Guo, an NIBIB PI, shows promise for developing ultrastable RNA nanoparticles that may help treat cancer and viral infections by regulating cell function and binding to cancers without harming surrounding tissue. Read the full article from University of Kentucky.